Enhanced In Vivo Tumor Detection by Active Tumor Cell Targeting Using Multiple Tumor Receptor-Binding Peptides Presented on Genetically Engineered Human Ferritin Nanoparticles
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwon, Koo Chul | - |
dc.contributor.author | Ko, Ho Kyung | - |
dc.contributor.author | Lee, Jiyun | - |
dc.contributor.author | Lee, Eun Jung | - |
dc.contributor.author | Kim, Kwangmeyung | - |
dc.contributor.author | Lee, Jeewon | - |
dc.date.accessioned | 2021-09-03T21:06:15Z | - |
dc.date.available | 2021-09-03T21:06:15Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2016-08-17 | - |
dc.identifier.issn | 1613-6810 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/87805 | - |
dc.description.abstract | Human ferritin heavy-chain nanoparticle (hFTH) is genetically engineered to present tumor receptor-binding peptides (affibody and/or RGD-derived cyclic peptides, named 4CRGD here) on its surface. The affibody and 4CRGD specifically and strongly binds to human epidermal growth factor receptor I (EGFR) and human integrin alpha v beta 3, respectively, which are overexpressed on various tumor cells. Through in vitro culture of EGFR-overexpressing adenocarcinoma (MDA-MB-468) and integrin-overexpressing glioblastoma cells (U87MG), it is clarified that specific interactions between receptors on tumor cells and receptor-binding peptides on engineered hFTH is critical in active tumor cell targeting. After labeling with the near-infrared fluorescence dye (Cy5.5) and intravenouse injection into MDA-MB-468 or U87MG tumor-bearing mice, the recombinant hFTHs presenting either peptide or both of affibody and 4CRGD are successfully delivered to and retained in the tumor for a prolonged period of time. In particular, the recombinant hFTH presenting both affibody and 4CRGD notably enhances in vivo detection of U87MG tumors that express heterogeneous receptors, integrin and EGFR, compared to the other recombinant hFTHs presenting either affibody or 4CRGD only. Like affibody and 4CRGD used in this study, other multiple tumor receptor-binding peptides can be also genetically introduced to the hFTH surface for actively targeting of in vivo tumors with heterogenous receptors. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY-V C H VERLAG GMBH | - |
dc.subject | PROTEIN NANOPARTICLES | - |
dc.subject | SURFACE MODIFICATION | - |
dc.subject | HIGH-AFFINITY | - |
dc.subject | H-CHAIN | - |
dc.subject | DELIVERY | - |
dc.subject | EXPRESSION | - |
dc.subject | MOLECULES | - |
dc.subject | AGENTS | - |
dc.subject | TRANSFERRIN | - |
dc.subject | REMOVAL | - |
dc.title | Enhanced In Vivo Tumor Detection by Active Tumor Cell Targeting Using Multiple Tumor Receptor-Binding Peptides Presented on Genetically Engineered Human Ferritin Nanoparticles | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Jeewon | - |
dc.identifier.doi | 10.1002/smll.201600917 | - |
dc.identifier.scopusid | 2-s2.0-84981507309 | - |
dc.identifier.wosid | 000383376300008 | - |
dc.identifier.bibliographicCitation | SMALL, v.12, no.31, pp.4241 - 4253 | - |
dc.relation.isPartOf | SMALL | - |
dc.citation.title | SMALL | - |
dc.citation.volume | 12 | - |
dc.citation.number | 31 | - |
dc.citation.startPage | 4241 | - |
dc.citation.endPage | 4253 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalResearchArea | Physics | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Physical | - |
dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Physics, Applied | - |
dc.relation.journalWebOfScienceCategory | Physics, Condensed Matter | - |
dc.subject.keywordPlus | PROTEIN NANOPARTICLES | - |
dc.subject.keywordPlus | SURFACE MODIFICATION | - |
dc.subject.keywordPlus | HIGH-AFFINITY | - |
dc.subject.keywordPlus | H-CHAIN | - |
dc.subject.keywordPlus | DELIVERY | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | MOLECULES | - |
dc.subject.keywordPlus | AGENTS | - |
dc.subject.keywordPlus | TRANSFERRIN | - |
dc.subject.keywordPlus | REMOVAL | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.